Catalent Inc
NYSE:CTLT
Catalent Inc
Net Change in Cash
Catalent Inc
Net Change in Cash Peer Comparison
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Catalent Inc
NYSE:CTLT
|
Net Change in Cash
-$213m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-38%
|
|
Johnson & Johnson
NYSE:JNJ
|
Net Change in Cash
-$1.4B
|
CAGR 3-Years
21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Net Change in Cash
$286m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-23%
|
|
Pfizer Inc
NYSE:PFE
|
Net Change in Cash
$2.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
10%
|
|
Merck & Co Inc
NYSE:MRK
|
Net Change in Cash
-$4.1B
|
CAGR 3-Years
-111%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Eli Lilly and Co
NYSE:LLY
|
Net Change in Cash
-$1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-36%
|
See Also
What is Catalent Inc's Net Change in Cash?
Net Change in Cash
-213m
USD
Based on the financial report for Dec 31, 2023, Catalent Inc's Net Change in Cash amounts to -213m USD.
What is Catalent Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
-38%
Over the last year, the Net Change in Cash growth was 48%.